BegleyCG, EllisLM (2012) Drug development: Raise standards for preclinical cancer research. Nature, 483(7391), 531–3.
2.
PrinzF, SchlangeT, AsadullahK (2011) Believe it or not: how much can we rely on published data on potential drug targets?. Nat Rev Drug Discov, 10(9), 712.
3.
SangaleZ, PrassC, CarlsonA, TikishviliE, DegradoJ, LanchburyJ, StoneS (2011) A robust immunohistochemical assay for detecting PTEN expression in human tumors. Appl. Immunohistochem. Mol. Morphol., 19(2), 173–83.
4.
ObersteMS, PallanschMA (2003) Establishing evidence for enterovirus infection in chronic disease. Ann. N. Y. Acad. Sci., 1005, 23–31.
5.
CoppietersKT, von HerrathM (2013) Antibody cross-reactivity and the viral aetiology of type 1 diabetes. J. Pathol., 230(1), 1–3.
6.
HanssonSF, KorsgrenS, PonténF, KorsgrenO (2013) Enteroviruses and the pathogenesis of type 1 diabetes revisited: cross-reactivity of enterovirus capsid protein (VP1) antibodies with human mitochondrial proteins. J. Pathol., 229(5), 719–28.
7.
RichardsonSJ, LeeteP, DhayalS, RussellMA, OikarinenM, LaihoJE, SvedinE, LindK, Rosen-lingT, ChapmanN, BoneAJ, FoulisAK, FriskG, Flodstrom-TullbergM, HoberD, HyotyH, MorganNG (2014) Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas. Diabetologia, 57(2), 392–401.
8.
MorensDM., PallanschMA., 1995. Epidemiology. In Human Enterovirus Infections, 3–23, ASM Press. Washington, D.C.
9.
PallanschMA., RoosRP., 2001. Enteroviruses: poliovirus, coxsackievirus, echovirus, and newer enteroviruses. In Field's Virology, 723-75. Lippincott/Williams & Wilkins. Philadelphia/ Baltimore.
